Back to Journals » Oncolytic Virotherapy » Volume 3

Oncolytic Virotherapy

Archive: Volume 3, 2014

Immune cells: more than simple carriers for systemic delivery of oncolytic viruses

Eisenstein S, Chen SH, Pan PY

Oncolytic Virotherapy 2014, 3:83-91

Published Date: 6 November 2014

Reovirus in cancer therapy: an evidence-based review

Clements D, Helson E, Gujar SA, Lee PWK

Oncolytic Virotherapy 2014, 3:69-82

Published Date: 9 July 2014

Live attenuated measles virus vaccine therapy for locally established malignant glioblastoma tumor cells

Al-Shammari AM, Ismaeel FE, Salih SM, Yaseen NY

Oncolytic Virotherapy 2014, 3:57-68

Published Date: 3 May 2014

Applications of coxsackievirus A21 in oncology

Bradley S, Jakes AD, Harrington K, Pandha H, Melcher A, Errington-Mais F

Oncolytic Virotherapy 2014, 3:47-55

Published Date: 10 April 2014

Oncolytic viral therapy for pancreatic cancer: current research and future directions

Ady JW, Heffner J, Klein E, Fong Y

Oncolytic Virotherapy 2014, 3:35-46

Published Date: 17 February 2014

Oncolytic viral therapy: targeting cancer stem cells

Smith TT, Roth JC, Friedman GK, Gillespie GY

Oncolytic Virotherapy 2014, 3:21-33

Published Date: 7 February 2014